Anti-MOG antibody-associated disorders: differences in clinical profiles and prognosis in Japan and Germany.
Jia LiuMasahiro MoriHanna ZimmermannAlexander BrandtJoachim HavlaSatoru TanakaKazuo SugimotoSatoru OjiAkiyuki UzawaSusanna AsseyerGraham CooperSven JariusJudith Bellmann-StroblKlemens RuprechtNadja SiebertHiroki MasudaTomohiko UchidaRyohei OhtaniKyoichi NomuraEdgar MeinlTania KuempfelFriedemann PaulSatoshi KuwabaraPublished in: Journal of neurology, neurosurgery, and psychiatry (2020)
Among patients with MOG-IgG, Japanese tended to have a monophasic milder disease, whereas the majority of German patients had a relapsing course and more frequent myelitis, findings compatible with neuromyelitis optica spectrum disorder. Although the attack-prevention treatment regimens were considerably different, genetic and environmental factors may be important to determine clinical phenotypes and disease activity.